VC
Denmark
In The News Sept 2026

Sunstone Life Science Ventures

Check Size
€1M – €15M

Investment Focus

Sectors

Investment Stages

Geographic Focus

Denmark
Europe

Investment Thesis

Danish life science VC backing early-stage European biotech companies developing novel human therapeutics, entering at pre-clinical to Phase I stage.

How to Pitch Sunstone Life Science Ventures

No Stated Policy
Sunstone Life Science Ventures hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Portfolio Highlights

Cardior Pharmaceuticals - RNA cardiovascular therapy (acquired by Novo Nordisk for >€1B)
Forendo Pharma - endometriosis treatment (acquired by Organon 2021)
DiogenX - recombinant protein therapy for type 1 diabetes

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach Sunstone Life Science Ventures?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.